Jane Street Group, LLC Bio Techne Corp Call Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$70.96 - $82.35 $1.15 Million - $1.33 Million	16,200 New	16,200 $1.29 Million
Q1 2022 May 17, 2022	BUY	$353.85 - $487.79 $5.17 Million - $7.12 Million	14,600 Added 211.59%	21,500 $9.31 Million
Q4 2021 Feb 15, 2022	SELL	$456.15 - $525.06 $4.84 Million - $5.57 Million	-10,600 Reduced 60.57%	6,900 $3.57 Million
Q3 2021 Nov 16, 2021	SELL	$444.87 - $538.88 $2.54 Million - $3.07 Million	-5,700 Reduced 24.57%	17,500 $8.48 Million
Q2 2021 Aug 16, 2021	BUY	$387.35 - $450.26 $8.44 Million - $9.82 Million	21,800 Added 1557.14%	23,200 $10.4 Million
Q1 2021 May 18, 2021	BUY	$314.62 - $411.0 $220,234 - $287,700	700 Added 100.0%	1,400 $535,000
Q4 2020 Feb 17, 2021	BUY	$246.9 - $321.87 $172,830 - $225,309	700 New	700 $222,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.98B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.